Navigation Links
Charles Drew cancer studies with yeast yield excellent results
Date:2/2/2010

duct clinical trials to determine safety, efficacy of dosage and a method of treatment.

Born in Egypt, Dr. Ghoneum earned his Ph.D. at the University of Tokyo in 1980 and did his postdoctoral studies at UCLA, School of Medicine. Dr. Ghoneum is an internationally recognized immunologist, who is an expert in Cancer Immune Therapy. He holds patents for inventing three biological response modifiers for the treatment of cancer. He has been a researcher and professor at Charles Drew University for twenty-five years, specializing in identifying natural cures for cancer.

Dr. Ghoneum's work has been studied and duplicated by leading scientists worldwide with results published in top medical journals. His findings have been confirmed by similar studies at the U.S. Department of Health and Science, National Institute of Health (NIH).

"There is a possibility that we could find a way to treat not only the local tumor, but the tumor that has spread throughout the body," said Dr. Gus Gill, Chairman Emeritus, Department of Otolaryngology, Charles Drew University. "As a surgeon, I always thought that a better way was to try to get rid of surgery (as a necessity) when dealing with cancer."


'/>"/>

Contact: Elia Esparza
eliaesparza@cdrewu.edu
323-563-5822
Charles Drew University of Medicine and Science
Source:Eurekalert  

Page: 1 2

Related biology news :

1. The surprising story of Charles Darwin and his homeopathic doctor
2. TSC honors Sen. Charles Schumer
3. GEN joins Charles Darwin 2009 celebration
4. Pest management specialist Charles Summers wins prestigious Woodworth Award
5. Why do we choose our mates? Ask Charles Darwin, prof says
6. 2009 Charles River Laboratories Excellence in Refinement Award
7. Charles Darwin really did have advanced ideas about the origin of life
8. Charles Darwin and modern biology
9. Charles Darwin: More than the origin
10. Green tea boosts production of detox enzymes, rendering cancerous chemicals harmless
11. A study by the MUHC and McGill University opens a new door to understanding cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Charles Drew cancer studies with yeast yield excellent results
(Date:2/24/2015)... , Feb. 24, 2015 This report analyzes the ... provides separate comprehensive analytics for the US, Canada ... , Asia-Pacific , Middle ... Annual estimates and forecasts are provided for the period 2013 ... these markets. Market data and analytics are derived from primary ...
(Date:2/18/2015)... (NASDAQ: CPHD ) today announced that its executives ... to participate via webcast. , Cowen and Company Health ... 3, 2015 at 11.20 a.m. Eastern Time , Raymond ... Wednesday, March 4, 2015 at 10.25 a.m. Eastern Time ... these events, please visit Cepheid,s website at http://ir.cepheid.com ...
(Date:2/10/2015)... Inc. (NYSE: ALR), a global leader in rapid ... ended December 31, 2014. Namal Nawana, ... "We made substantial progress in the fourth quarter ... rapid diagnostics and delivering against our financial plans.  ... January enabled us to substantially reduce our debt, ...
Breaking Biology News(10 mins):World Iris Biometrics Industry 2World Iris Biometrics Industry 3World Iris Biometrics Industry 4World Iris Biometrics Industry 5World Iris Biometrics Industry 6World Iris Biometrics Industry 7World Iris Biometrics Industry 8World Iris Biometrics Industry 9World Iris Biometrics Industry 10World Iris Biometrics Industry 11Cepheid to Webcast Upcoming Financial Presentations 2Alere Inc. Announces Fourth Quarter 2014 Results 2Alere Inc. Announces Fourth Quarter 2014 Results 3Alere Inc. Announces Fourth Quarter 2014 Results 4Alere Inc. Announces Fourth Quarter 2014 Results 5Alere Inc. Announces Fourth Quarter 2014 Results 6Alere Inc. Announces Fourth Quarter 2014 Results 7Alere Inc. Announces Fourth Quarter 2014 Results 8Alere Inc. Announces Fourth Quarter 2014 Results 9Alere Inc. Announces Fourth Quarter 2014 Results 10Alere Inc. Announces Fourth Quarter 2014 Results 11Alere Inc. Announces Fourth Quarter 2014 Results 12Alere Inc. Announces Fourth Quarter 2014 Results 13Alere Inc. Announces Fourth Quarter 2014 Results 14Alere Inc. Announces Fourth Quarter 2014 Results 15Alere Inc. Announces Fourth Quarter 2014 Results 16Alere Inc. Announces Fourth Quarter 2014 Results 17Alere Inc. Announces Fourth Quarter 2014 Results 18Alere Inc. Announces Fourth Quarter 2014 Results 19Alere Inc. Announces Fourth Quarter 2014 Results 20Alere Inc. Announces Fourth Quarter 2014 Results 21Alere Inc. Announces Fourth Quarter 2014 Results 22Alere Inc. Announces Fourth Quarter 2014 Results 23Alere Inc. Announces Fourth Quarter 2014 Results 24Alere Inc. Announces Fourth Quarter 2014 Results 25
... protein discovered by Temple University researchers, may also ... in treating leukemia, according to a study by ... Inhibitor, Angiocidin, Induces Differentiation of Monocytes to Macropahges," ... of the journal Cancer Research ( ...
... is known about the world,s largest living turtle, the leatherback. ... hard shell, the behavior and habitats of this critically endangered ... Biology , marine biologist Barbara Block and colleagues give us ... turtles, behavior, in doing so, providing methods that could be ...
... The forests of the future may need to be managed ... any other goal, researchers say in a new federal report ... fix" to the insatiable, often conflicting demands for this precious ... say, as both urban and agricultural demands for water continue ...
Cached Biology News:Tumor-inhibiting protein could be effective in treating leukemia 2Leatherback turtles go with the flow 2New report: Greatest value of forests is sustainable water supply 2New report: Greatest value of forests is sustainable water supply 3
(Date:2/27/2015)... 2015  Pharmacyclics, Inc. (NASDAQ: PCYC ... its newly developed Bruton,s tyrosine kinase (BTK) inhibitor ... The results of these preclinical evaluations have been ... The feedback received from the Agency is supportive ... Additional preclinical work is required to begin a ...
(Date:2/27/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/p2ddnr/global_market ) has announced ... report to their offering. , Global ... data on Trypsin globally and regionally ( Europe ... , Latin America etc.). It ... This report focuses on three primary areas; manufacture methods ...
(Date:2/27/2015)... Md. (PRWEB) February 27, 2015 ... Chromatography system (Nexera UC) can sequentially analyze up ... separation combined with high-sensitivity detection of targets by ... is designed to fulfill the measurement requirements of ... in food products, drug delivery and search for ...
(Date:2/27/2015)... , Feb. 27, 2015  Pfenex Inc. (NYSE ... development of biosimilar therapeutics, today announced that it will ... Marriott Marquis on March 2 nd at 3pm ... on a panel discussing the current state of the ... Biosimilars . For more information on ...
Breaking Biology Technology:Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 2Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 3Global Market Report of Trypsin 2014-2018 2Shimadzu Corporation Launches Nexera UC - The World’s Foremost Unified Chromatography System 2Shimadzu Corporation Launches Nexera UC - The World’s Foremost Unified Chromatography System 3
... ... Particle Characterization”, will be presented on December 2, 2009. In this webinar, the ... optimize a series of roller compaction runs while varying raw materials, flow rates, and ... ...
... , , SEATTLE, Nov. 19 Omeros Corporation (Nasdaq: ... quarter ended September 30, 2009. For the three months ended September ... $1.34 per share, as compared to a net loss of $7.4 ... For the nine months ended September 30, 2009, the Company reported ...
... BETHESDA, Md., Nov. 19 Spherix Incorporated (Nasdaq: ... and a provider of technical and regulatory consulting services ... the results of Tuesday,s Annual Meeting of Shareholders. , ... SPEX ) elected the following members to the Board ...
Cached Biology Technology:Roller Compaction Process Optimization Using At-Line Particle Characterization 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8Spherix Announces Results of Annual Shareholders Meeting 2Spherix Announces Results of Annual Shareholders Meeting 3Spherix Announces Results of Annual Shareholders Meeting 4
RayBio L Series 507: RayBio Label-based Antibody Array I (2 membranes) Class: Antibody Array Products Product Group: Antibody Array...
Human HVEM/TNFRSF14 Allophycocyanin MAb (Clone 94801)...
... High Sensitivity Freezing Point Osmometer for ... small volume applications, including pediatric, neonatal, ... animals. Automatic Calibration with 2 ... built-in printer, keypad and software for ...
uncoupling protein 2 (mitochondrial, proton carrier), mRNA (cDNA clone MGC:19567 IMAGE:4335185), complete cds...
Biology Products: